Eterna Therapeutics (ERNA)
NASDAQ:ERNA
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 17, 2026 | xxxxxxxxxxxxx | $2000000 | |
Jun 11, 2025 | xxxxxxxxxxxxx | $2124116 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,779,440 | Insider | 23.25% | 1,369,447 | |
| 16,242 | Institution | 0.06% | 3,281 | |
| 10,475 | Institution | 0.04% | 2,116 | |
| 10,475 | Institution | 0.04% | 2,116 | |
| 110 | Insider | <0.01% | 22 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,242 | Institution | 0.06% | 3,281 | |
| 10,475 | Institution | 0.04% | 2,116 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,475 | Institution | 0.04% | 2,986 |
FAQ
Who Owns Eterna Therapeutics (ERNA)?
Currently, no data Available
What percentage of Eterna Therapeutics (ERNA) stock is held by institutional investors?
Currently, no data Available
What percentage of Eterna Therapeutics (ERNA) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Eterna Therapeutics (ERNA)?
Charles Cherington owns the most shares of Eterna Therapeutics (ERNA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.